Zhengye Biotechnology Holding

General Information

We are a holding company incorporated in the Cayman Islands. Our underlying business is a Chinese company that makes and distributes vaccines for livestock. (Incorporated in the Cayman Islands) 

We, through the operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. For nearly 20 years, the operating entity has been committed to enhancing the health of livestock. The operating entity markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry and dogs. The operating entity’s products are available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.

*Note: Net income and revenue are in U.S. dollars (converted from China’s currency) for the 12 months that ended June 30, 2023.

(Zhengye Biotechnology Holding filed its F-1 on Jan. 9, 2024, without disclosing terms for its IPO. The company submitted its confidential IPO documents to the SEC in August 2023.)

Employees: 299
Founded: 2004
Contact Information
Address No.1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin City, Jilin Province, China
Phone Number +86-0432-63047008
Web Address http://www.jlzybio.com/
View Prospectus: Zhengye Biotechnology Holding
Financial Information
Market Cap
Revenues $36.8 mil (last 12 months)
Net Income $7.6 mil (last 12 months)
IPO Profile
Symbol ZYBT
Exchange NASDAQ
Shares (millions): 0.0
Price range $0.00 - $0.00
Est. $ Volume $20.0 mil
Manager / Joint Managers US Tiger Securities Inc.
Expected To Trade:
Status: TBA
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change